February 11, 2015
A New York federal judge on Tuesday rejected Teva Pharmaceuticals USA Inc.'s bid to block sales of generic versions of its multiple sclerosis drug Copaxone following a recent U.S. Supreme Court patent decision, ruling that he had no authority to grant Teva's request.
February 02, 2015
Teva Pharmaceuticals USA Inc. asked a federal judge Friday to block sales of generic versions of its multiple sclerosis drug Copaxone during the remand of a recent U.S. Supreme Court ruling that vacated a decision invalidating a key patent covering the drug.
June 25, 2012
In a major win for Teva Pharmaceutical Industries Ltd., a judge has ruled that Mylan Pharmaceuticals Inc. and Sandoz Inc. infringed the Israeli drugmaker's patents for Copaxone in making generic versions of the multiple sclerosis drug.